Primary completion· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Zasocitinib History and Updates
31 events · 2024 – present
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
0
FDA Approvals
0
Label Revisions
31
Trial Milestones
0
Pivotal Publications
Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-06-18Download chart as PNG
This page tracks every FDA action, clinical trial milestone, and major publication for Zasocitinib since 2024, drawn from openFDA, ClinicalTrials.gov, and PubMed.
Upcoming & expected milestones
Primary completion· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Primary completion· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Primary completion· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Primary completion· ClinicalTrials.gov
A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
Primary completion· ClinicalTrials.gov
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Primary completion· ClinicalTrials.gov
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Primary completion· ClinicalTrials.gov
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Past events
2026
Trial started· ClinicalTrials.gov
A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
Trial started· ClinicalTrials.gov
A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
Primary completion· ClinicalTrials.gov
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Trial started· ClinicalTrials.gov
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Trial registered· ClinicalTrials.gov
A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
Trial started· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
2025
Trial registered· ClinicalTrials.gov
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Trial started· ClinicalTrials.gov
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Trial registered· ClinicalTrials.gov
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Trial registered· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Trial started· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Trial registered· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Trial started· ClinicalTrials.gov
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Trial started· ClinicalTrials.gov
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Trial registered· ClinicalTrials.gov
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Primary completion· ClinicalTrials.gov
A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults
Trial started· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Trial started· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Trial registered· ClinicalTrials.gov
A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults
Trial started· ClinicalTrials.gov
A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults
Trial registered· ClinicalTrials.gov
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
2024
Trial registered· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Trial registered· ClinicalTrials.gov
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Sources
FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.